QA: Orgenesis Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001460602_2023_Orgenesis_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001460602, Orgenesis Inc

  xvar xval
0 AssetsCurrent 46,318,000
1 IntangibleAssetsNetIncludingGoodwill 17,881,000
2 PropertyPlantAndEquipmentNet 22,834,000
3 remainder_Assets 3,895,000
4 LiabilitiesCurrent 15,910,000
5 LiabilitiesNoncurrent 15,744,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 22,102,310
8 SellingGeneralAndAdministrativeExpense 15,967,348
9 ResearchAndDevelopmentExpense 5,093,301
10 remainder_Expenses 2,040,376
11 remainder_Revenues 36,625,632
12 remainder_NetIncome -3,382,994
13 remainder_ComprehensiveNetIncome -1,545,604
  yvar yval
0 Assets 90,928,000
1 Liabilities 31,654,000
2 Expenses 45,203,335
3 Revenues 36,625,632
4 StockholdersEquity 59,274,000
5 NetIncome -11,960,697
6 ComprehensiveNetIncome -12,733,499
7 BaseVar 104,669,782
8 EconomicCapitalRatiobeforeLimitedLiability 1.90
9 EconomicCapitalRatio 2.96

Edgar->Model Mapping

Feature Distribution

Change over Time